Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Colorcon
Moodys
Dow
Boehringer Ingelheim
Chinese Patent Office
Federal Trade Commission
McKinsey
Cerilliant

Generated: July 22, 2018

DrugPatentWatch Database Preview

Drug Master Files for: mirabegron

« Back to Dashboard


mirabegron Drug Master Files

DMF No. Status Type Submission Date Holder Subject
28071 A II 3/20/2014 MSN LABORATORIES PRIVATE LTD MIRABEGRON [ROUTE CODE MG]
28392 A II 6/30/2014 DR REDDYS LABORATORIES LTD MIRABEGRON [PRODUCT CODE: AEB]
28420 A II 6/25/2014 OPTIMUS DRUGS PRIVATE LTD (1R)-2-[(2-(4-NITROPHENYL) ETHYL] AMINO] -1- PHENYL ETHANOL. HCL (MIRABEGRON INTERMEDIATE)
29064 A II 2/27/2015 DR REDDYS LABORATORIES LTD MIRABEGRON [FORM - AMORPHOUS]
DMF No. Status Type Submission Date Holder Subject

This preview shows a limited data set. Subscribe for full access, or try a Free Trial


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Julphar
Citi
Farmers Insurance
McKinsey
Moodys
Queensland Health
Fuji
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.